A molecular mechanism underlying genotype‐specific intrahepatic cholestasis resulting from MYO5B mutations AW Overeem, Q Li, YL Qiu, F Cartón‐García, C Leng, K Klappe, ... Hepatology 72 (1), 213-229, 2020 | 42 | 2020 |
Unequal effects of myosin 5B mutations in liver and intestine determine the clinical presentation of low‐gamma‐glutamyltransferase cholestasis SCD van IJzendoorn, Q Li, Y Qiu, JS Wang, AW Overeem Hepatology 72 (4), 1461-1468, 2020 | 17 | 2020 |
A link between intrahepatic cholestasis and genetic variations in intracellular trafficking regulators Q Li, Y Sun, SCD van IJzendoorn Biology 10 (2), 119, 2021 | 12 | 2021 |
Loss of MYO5B expression deregulates late endosome size which hinders mitotic spindle orientation C Leng, AW Overeem, F Cartón-Garcia, Q Li, K Klappe, J Kuipers, Y Cui, ... PLoS biology 17 (11), e3000531, 2019 | 12 | 2019 |
A functional relationship between UNC45A and MYO5B connects two rare diseases with shared enteropathy Q Li, Z Zhou, Y Sun, C Sun, K Klappe, SCD van IJzendoorn Cellular and molecular gastroenterology and hepatology 14 (2), 295-310, 2022 | 9 | 2022 |
Uncovering the Relationship between Genes and Phenotypes Beyond the Gut in Microvillus Inclusion Disease M Sun, O Pylypenko, Z Zhou, M Xu, Q Li, A Houdusse, ... Cellular and Molecular Gastroenterology and Hepatology, 2024 | | 2024 |
MYO5B in health and disease Q Li | | 2023 |
Liver Cell Models for Premature Termination Codon Readthrough Analyses L Matakovic, Q Li, SCD van Ijzendoorn Hepatology 74 (3), 1711-1712, 2021 | | 2021 |
Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai: Rationale and Design of a Population-Based Comparative Study Y Du, Q Li, G Sidorenkov, M Vonder, J Cai, G De Bock, M Rook, ... Journal of Thoracic Oncology 14 (10), S526-S527, 2019 | | 2019 |